IP Library Granted Patent US 9,175,066
Granted Patent B2
US 9,175,066 · App. 13/262,725 · Granted Nov 3, 2015

Compositions containing HC-HA complex and methods of use thereof

Inventors: Scheffer Tseng (Pinecrest, FL); Hua He (Miami, FL)
Assignee: TISSUETECH, INC.
C07K14/78A61K47/481A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,066
App. No.
13/262,725
Granted
Nov 3, 2015
Kind
B2
Abstract

Disclosed herein, in certain embodiments, is an HC•HA complex comprising hyaluronan and a heavy chain of IαI, wherein the transfer of the heavy chain of IαI is catalyzed by TSG-6. Further disclosed herein, in certain embodiments, is an HC•HA complex comprising hyaluronan and a heavy chain of IαI, wherein the transfer of the heavy chain of IαI is catalyzed by the TSG-6 like protein. Additionally, disclosed herein are methods of manufacturing said complex and methods of use thereof.

Claims (13)

1. A method of producing a reconstituted HC•HA (rcHC•HA) complex, comprising

(a) providing HA Binding Protein (HABP) crosslinked to a stationary support;

(b) contacting the HABP crosslinked to the stationary support with

(i) hyaluronan (HA);

(ii) HC1 and HC2 of IαI; and

(iii) TSG-6; and

(c) incubating for a period of time sufficient to produce rcHC•HA complex.

2. The method of claim 1 , wherein HC1 and HC2 of IαI are isolated from serum.

3. The method of claim 1 , wherein at least one of HA, HC1, HC2, TSG-6, TSG-6-like protein is generated by a plurality of cells in the reaction mixture.

4. The method of claim 1 , further comprising isolating and purifying the rcHC•HA complex.

5. The method of claim 4 , wherein the rcHC•HA complex is isolated by centrifugation, filtration, or a combination thereof.

6. The method of claim 4 , wherein the rcHC•HA complex is purified by chromatography, gel filtration, centrifugation, differential solubility, ethanol precipitation, or a combination thereof.

7. The method of claim 6 , wherein the chromatography is affinity chromatography.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FINANCIAL TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0165 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FUNDING IV TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0200 →
CHANGE OF NAME Recorded May 22, 2023
From: TISSUETECH, INC.
To: BIOTISSUE HOLDINGS INC.
Reel/Frame 063713/0329 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - TERM LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060116/0413 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - REVOLVING LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 060116/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2012
From: TSENG, SCHEFFER; HE, HUA
To: TISSUETECH, INC.
Reel/Frame 027791/0833 →
Continuity (3)
Provisional Application 61172621 · Apr 24, 2009
Provisional Application 61267776 · Dec 8, 2009
Related Publication 20120083445A1 · Apr 5, 2012